Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Noro-Moseley Partners (NMP) is a venture capital firm founded in 1983 and headquartered in Atlanta, Georgia. The firm has established itself as one of the longest-running venture capital firms in the Southeastern United States. NMP focuses on early growth equity investments, primarily in B2B technology and healthcare sectors. Over the years, the firm has built a reputation for identifying and supporting companies that demonstrate compelling growth potential.
Currently, NMP manages a diverse portfolio and has a strong presence in the venture capital landscape. The firm typically invests between $5 million and $20 million in companies that exhibit year-over-year growth of 50% or more. NMP's investment strategy is characterized by its commitment to fostering innovation and driving success in its portfolio companies. The firm operates from its office in Atlanta, Georgia, and has a network of limited partners that support its investment activities.
Noro-Moseley Partners invests in emerging technology and healthcare innovations across the United States. The firm targets companies that demonstrate year-over-year growth of 50% or more, compelling unit economics, and a revenue run rate between $2 million and $20 million. NMP typically invests between $5 million and $20 million, focusing on seed-plus, Series A, and growth equity stages. This investment strategy allows NMP to engage with businesses that have significant opportunities for market disruption and minimal prior funding.
The firm emphasizes its expertise in B2B technology and healthcare sectors, seeking companies that can leverage their innovative solutions to create substantial market impact. NMP's investment thesis revolves around identifying businesses that not only have strong financial metrics but also possess the potential to disrupt existing markets. This focus on high-growth sectors positions NMP as a valuable partner for startups aiming to scale rapidly.
Noro-Moseley Partners has built a diverse portfolio that includes a variety of companies across different sectors. Notable companies in their portfolio include:
Allen Moseley - Managing General Partner. Allen has extensive experience in venture capital and has led numerous successful investments in the technology and healthcare sectors.
Alan Taetle - General Partner. Alan brings a wealth of knowledge in early-stage investing and has a strong track record of supporting high-growth companies.
Spence McClelland - General Partner. Spence specializes in B2B technology investments and has played a key role in the firm's strategic direction.
Vasant Kamath - General Partner. Vasant has a background in technology and healthcare, focusing on identifying disruptive innovations.
Ryan Collins - Principal. Ryan is involved in sourcing and evaluating new investment opportunities, with a keen eye for market trends.
Elizabeth Stephens - Principal. Elizabeth focuses on operational support for portfolio companies, helping them scale effectively.
Bill Hudson - Administrative Partner, CFO. Bill oversees the firm's financial operations and ensures compliance with regulatory requirements.
Thomas Collier - Associate. Thomas assists in deal sourcing and due diligence processes.
Missy Evans - Executive Assistant and Office Manager. Missy manages office operations and supports the team in various administrative capacities.
George Mori - Business Development Analyst. George focuses on identifying new business opportunities and partnerships for the firm.
Noro-Moseley Partners prefers to receive pitches through their website or direct contact. Founders should include a comprehensive pitch deck that outlines the business model, market opportunity, and financial projections. Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
Noro-Moseley Partners has been actively investing in a diverse range of sectors, including SaaS, healthcare, and biotech. Their portfolio features companies such as Allergy and Asthma Services and a Warehouse Planning and Optimization Platform, indicating a commitment to emerging technology and healthcare innovations.
As of March 2023, NMP continues to seek out high-growth investment opportunities, particularly in the Southeastern United States. The firm remains focused on supporting companies that demonstrate significant market disruption potential.
What are Noro-Moseley Partners' investment criteria?
NMP invests in B2B technology and healthcare companies that demonstrate year-over-year growth of 50% or more, compelling unit economics, and a revenue run rate between $2 million and $20 million.
How can I apply or pitch to Noro-Moseley Partners?
Founders can reach out through the firm's website or contact them directly via telephone. A well-prepared pitch deck that outlines the business model, market opportunity, and financial projections is recommended.
What makes Noro-Moseley Partners different from other VC firms?
NMP has a long-standing presence in the venture capital space, focusing specifically on early growth equity investments in high-potential B2B technology and healthcare sectors. Their extensive experience and regional expertise provide valuable insights for portfolio companies.
What is the geographic scope of Noro-Moseley Partners?
NMP primarily invests in companies based in the United States, with a strong focus on the Southeastern region.
What is Noro-Moseley Partners' post-investment involvement like?
NMP adds value through strategic guidance, operational support, and leveraging its extensive network within the B2B technology and healthcare sectors, helping portfolio companies achieve their growth objectives.
What is the typical fund size and check size for Noro-Moseley Partners?
NMP typically invests between $5 million and $20 million in each portfolio company, focusing on early growth equity stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.